Medicare Enrolled
Dr. Rahil Kazi, M.D.
Cardiovascular Disease · Warner Robins, GA
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kazi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kazi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kazi
Dr. Rahil Kazi is a cardiovascular disease specialist in Warner Robins, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kazi performed 12,191 Medicare services across 7,215 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kazi received a total of $33,007 from 34 pharmaceutical and/or device companies across 350 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kazi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in GA
$33,007 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,191
Medicare services
Top 1% in GA for cardiovascular disease
7,215
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~610 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,752 | $86 | $170 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
2,416 | $10 | $85 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
1,324 | $43 | $78 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,118 | $61 | $125 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
789 | $134 | $1,208 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
781 | $86 | $180 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
476 | $6 | $59 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
435 | $45 | $495 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
391 | $303 | $1,500 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
213 | $47 | $491 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
210 | $18 | $85 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
209 | $43 | $65 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
194 | $36 | $140 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
184 | $107 | $240 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
107 | $10 | $100 |
| Cardiac catheterization | 90 | $216 | $2,179 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
87 | $57 | $500 |
| Implantable defibrillator system check A check of the implanted defibrillator device to ensure it is functioning correctly. This evaluation covers single, dual, or multiple lead systems. |
82 | $44 | $190 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
58 | $99 | $277 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
52 | $88 | $500 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
51 | $103 | $620 |
| CT scan of heart blood vessels and grafts with contrast A CT scan that uses contrast dye to create detailed images of the heart's blood vessels and any surgical grafts. |
48 | $189 | $2,198 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
44 | $58 | $144 |
| Complete ultrasound of abdomen A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen. |
25 | $51 | $344 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
22 | $108 | $697 |
| Injection, dobutamine hydrochloride, per 250 mg | 17 | $7 | $50 |
| CT scan of lower leg blood vessels with contrast A CT scan that uses contrast dye to create detailed images of the blood vessels in the lower leg. |
16 | $178 | $1,712 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.5% high complexity
26.7% medium
63.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$33,007
Total received (2018-2024)
Avg $4,715/year across 7 years
Top 9% in GA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
350
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,644 (47.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,224 (31.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,139 (21.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$811
2023
$639
2022
$888
2021
$720
2020
$1,527
2019
$4,147
2018
$24,275
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$172
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$113
Janssen Pharmaceuticals, Inc
$88
Amgen Inc.
$81
Novartis Pharmaceuticals Corporation
$57
Merck Sharp & Dohme LLC
$47
Boston Scientific Corporation
$46
Bayer Healthcare Pharmaceuticals Inc.
$38
Abbott Laboratories
$33
SANOFI-AVENTIS U.S. LLC
$22
PFIZER INC.
$19
Siemens Medical Solutions USA, Inc.
$19
Medtronic, Inc.
$17
AstraZeneca Pharmaceuticals LP
$16
Esperion Therapeutics, Inc.
$15
Lexicon Pharmaceuticals, Inc.
$14
Kiniksa Pharmaceuticals International, plc
$14
Top 3 companies account for 45.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$8,469
Amgen Inc.
$7,560
SANOFI-AVENTIS U.S. LLC
$6,924
Medtronic Vascular, Inc.
$4,741
AstraZeneca Pharmaceuticals LP
$1,334
Cardiovascular Systems Inc.
$785
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$630
E.R. Squibb & Sons, L.L.C.
$434
Janssen Pharmaceuticals, Inc
$341
Esperion Therapeutics, Inc.
$236
Boehringer Ingelheim Pharmaceuticals, Inc.
$211
Boston Scientific Corporation
$202
Amarin Pharma Inc.
$167
PFIZER INC.
$155
Abbott Laboratories
$149
Merck Sharp & Dohme LLC
$142
Regeneron Healthcare Solutions, Inc.
$85
Siemens Medical Solutions USA, Inc.
$58
Gilead Sciences, Inc.
$46
Bayer HealthCare Pharmaceuticals Inc.
$39
Bayer Healthcare Pharmaceuticals Inc.
$38
iRhythm Technologies, Inc.
$30
Merck Sharp & Dohme Corporation
$29
Kiniksa Pharmaceuticals, Ltd.
$26
Baxter Healthcare
$24
SCPHARMACEUTICALS INC.
$22
Lilly USA, LLC
$20
Novo Nordisk Inc
$20
Cook Medical LLC
$17
Medtronic, Inc.
$17
Alexion Pharmaceuticals, Inc.
$15
Lexicon Pharmaceuticals, Inc.
$14
Aziyo Biologics, Inc.
$14
Kiniksa Pharmaceuticals International, plc
$14
Top 3 companies account for 69.5% of all-time payments
Associated products mentioned in payments ›
ACUSON Sequoia Diagnostic Ultrasound System · Advisa · Arcalyst · Artis icono floor · BRILINTA · CAMZYOS · CARDIOMEMS · CHANTIX · Cook Medical Introducers · CoreValve Evolut · Corlanor · ECM · ELIQUIS · ENTRESTO · FARXIGA · FLOSEAL · FUROSCIX · JARDIANCE · JOT DX · Kerendia · LEQVIO · LINQ II · LUX-Dx Insertable Cardiac Monitor · LifeVest · MOUNJARO · MULTAQ · MitraClip System · NEXLETOL · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · Quadra Assura CRT Defibrillator · Repatha · Resolute · Reveal LINQ · Symbia_Evo · TYRX · ULTOMIRIS · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (47%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for cardiovascular disease in GA.
Geographic Context
Cardiologists within 10 mi
23
Per 100K population
13.8
County median income
$80,743
Nearest hospital
EMORY HOUSTON HOSPITAL WARNER ROBINS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kazi is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 1% in GA), with speaking/promotional industry engagement in the top 9% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kazi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kazi performed 2,752 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kazi receive payments from pharmaceutical companies?
Yes. Dr. Kazi received a total of $33,007 from 34 companies across 350 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kazi's costs compare to other cardiologists in Warner Robins?
Dr. Kazi's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kazi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Warner Robins
Browse cardiologists in Warner Robins ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in GA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in GA
Which GA cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology